Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L Heil

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Diagnostic Microbiology and Infectious Disease|February 17, 2018
The Verigene dilemma: gram-negative polymicrobial bloodstream infections and clinical decision makingKimberly C Claeys, Emily L Heil, Jason M Pogue, et al.
Journal of Interprofessional Care|October 8, 2016
Advancing interprofessional patient safety education for medical, nursing, and pharmacy learners during clinical rotationsKerri A Thom, Emily L Heil, Lindsay D Croft, et al.
Infection Control and Hospital Epidemiology|December 10, 2020
Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease 2019Jacqueline T Bork, Surbhi Leekha, Kimberly Claeys, et al.
Pharmacotherapy|July 27, 2025
A Large Cohort Study to Identify Risk Factors of Acute Kidney Injury in Pediatric Patients Undergoing Intravenous Vancomycin TherapyRahul K Goyal, Brady S Moffett, Kristine A Parbuoni, et al.
Surgical Infections|February 11, 2021
Evaluation of Intra-Operative Topical Vancomycin and the Incidence of Acute Kidney InjuryAlison L Blackman, Manjari Joshi, James Doub, et al.
Surgical Infections|August 21, 2015
Validation of a Dosing Strategy for Cefazolin for Surgery Requiring Cardiopulmonary BypassAllison L Hollis, Emily L Heil, David P Nicolau, et al.
Infectious Diseases and Therapy|May 5, 2019
Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive InfectionsJacqueline T Bork, Emily L Heil, Shanna Berry, et al.
Pharmacotherapy|October 28, 2020
Reply to Letters to the EditorAna Vega, Emily L Heil, Alison Blackman, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2020
A Propensity Score Matched Study of the Positive Impact of Infectious Diseases Consultation on Antimicrobial Appropriateness in Hospitalized Patients with Antimicrobial Stewardship OversightJacqueline T Bork, Kimberly C Claeys, Emily L Heil, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2012
Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infectionsEmily L Heil, Lindsay M Daniels, Dustin M Long, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Diagnostic Microbiology and Infectious Disease|February 17, 2018
The Verigene dilemma: gram-negative polymicrobial bloodstream infections and clinical decision makingKimberly C Claeys, Emily L Heil, Jason M Pogue, et al.
Journal of Interprofessional Care|October 8, 2016
Advancing interprofessional patient safety education for medical, nursing, and pharmacy learners during clinical rotationsKerri A Thom, Emily L Heil, Lindsay D Croft, et al.
Infection Control and Hospital Epidemiology|December 10, 2020
Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease 2019Jacqueline T Bork, Surbhi Leekha, Kimberly Claeys, et al.
Pharmacotherapy|July 27, 2025
A Large Cohort Study to Identify Risk Factors of Acute Kidney Injury in Pediatric Patients Undergoing Intravenous Vancomycin TherapyRahul K Goyal, Brady S Moffett, Kristine A Parbuoni, et al.
Surgical Infections|February 11, 2021
Evaluation of Intra-Operative Topical Vancomycin and the Incidence of Acute Kidney InjuryAlison L Blackman, Manjari Joshi, James Doub, et al.
Surgical Infections|August 21, 2015
Validation of a Dosing Strategy for Cefazolin for Surgery Requiring Cardiopulmonary BypassAllison L Hollis, Emily L Heil, David P Nicolau, et al.
Infectious Diseases and Therapy|May 5, 2019
Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive InfectionsJacqueline T Bork, Emily L Heil, Shanna Berry, et al.
Pharmacotherapy|October 28, 2020
Reply to Letters to the EditorAna Vega, Emily L Heil, Alison Blackman, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2020
A Propensity Score Matched Study of the Positive Impact of Infectious Diseases Consultation on Antimicrobial Appropriateness in Hospitalized Patients with Antimicrobial Stewardship OversightJacqueline T Bork, Kimberly C Claeys, Emily L Heil, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 1, 2012
Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infectionsEmily L Heil, Lindsay M Daniels, Dustin M Long, et al.
Pageof 12